244 related articles for article (PubMed ID: 26172280)
1. Differential Expression Analysis by RNA-Seq Reveals Perturbations in the Platelet mRNA Transcriptome Triggered by Pathogen Reduction Systems.
Osman A; Hitzler WE; Ameur A; Provost P
PLoS One; 2015; 10(7):e0133070. PubMed ID: 26172280
[TBL] [Abstract][Full Text] [Related]
2. Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function.
Osman A; Hitzler WE; Meyer CU; Landry P; Corduan A; Laffont B; Boilard E; Hellstern P; Vamvakas EC; Provost P
Platelets; 2015; 26(2):154-63. PubMed ID: 24749844
[TBL] [Abstract][Full Text] [Related]
3. Peculiarities of studying the effects of pathogen reduction technologies on platelets.
Osman A; Hitzler WE; Provost P
Proteomics Clin Appl; 2016 Aug; 10(8):805-15. PubMed ID: 27095411
[TBL] [Abstract][Full Text] [Related]
4. The platelets' perspective to pathogen reduction technologies.
Osman A; Hitzler WE; Provost P
Platelets; 2018 Mar; 29(2):140-147. PubMed ID: 28355122
[TBL] [Abstract][Full Text] [Related]
5. Pathogen reduction technologies: The pros and cons for platelet transfusion.
Magron A; Laugier J; Provost P; Boilard E
Platelets; 2018 Jan; 29(1):2-8. PubMed ID: 28523956
[TBL] [Abstract][Full Text] [Related]
6. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
[TBL] [Abstract][Full Text] [Related]
7. Activating stimuli induce platelet microRNA modulation and proteome reorganisation.
Cimmino G; Tarallo R; Nassa G; De Filippo MR; Giurato G; Ravo M; Rizzo F; Conte S; Pellegrino G; Cirillo P; Calabro P; Öhman T; Nyman TA; Weisz A; Golino P
Thromb Haemost; 2015 Jul; 114(1):96-108. PubMed ID: 25903651
[TBL] [Abstract][Full Text] [Related]
8. Biomolecular Consequences of Platelet Pathogen Inactivation Methods.
Feys HB; Van Aelst B; Compernolle V
Transfus Med Rev; 2019 Jan; 33(1):29-34. PubMed ID: 30021699
[TBL] [Abstract][Full Text] [Related]
9. Effects of intercept pathogen inactivation on platelet function as analysed by free oscillation rheometry.
Tynngård N; Johansson BM; Lindahl TL; Berlin G; Hansson M
Transfus Apher Sci; 2008 Feb; 38(1):85-8. PubMed ID: 18294916
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNAs in platelet biology during storage.
Yan Y; Zhang J; Zhang Q; Chen Y; Zhu X; Xia R
Transfus Apher Sci; 2017 Apr; 56(2):147-150. PubMed ID: 27815141
[TBL] [Abstract][Full Text] [Related]
11. miR-570 interacts with mitochondrial ATPase subunit g (ATP5L) encoding mRNA in stored platelets.
Dahiya N; Sarachana T; Kulkarni S; Wood WH; Zhang Y; Becker KG; Wang BD; Atreya CD
Platelets; 2017 Jan; 28(1):74-81. PubMed ID: 27561077
[TBL] [Abstract][Full Text] [Related]
12. Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.
Cid J; Magnano L; Molina P; Diaz-Ricart M; Martínez N; Maymó RM; Puig L; Lozano M; Escolar G; Galán AM
Transfusion; 2014 Feb; 54(2):426-33. PubMed ID: 23721299
[TBL] [Abstract][Full Text] [Related]
13. Pathogen inactivation with amotosalen plus UVA illumination minimally impacts microRNA expression in platelets during storage under standard blood banking conditions.
Arnason NA; Johannson F; Landrö R; Hardarsson B; Irsch J; Gudmundsson S; Rolfsson O; Sigurjonsson OE
Transfusion; 2019 Dec; 59(12):3727-3735. PubMed ID: 31674051
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
Apelseth TØ; Bruserud Ø; Wentzel-Larsen T; Bakken AM; Bjørsvik S; Hervig T
Transfusion; 2007 Apr; 47(4):653-65. PubMed ID: 17381624
[TBL] [Abstract][Full Text] [Related]
15. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation.
Hechler B; Ohlmann P; Chafey P; Ravanat C; Eckly A; Maurer E; Mangin P; Isola H; Cazenave JP; Gachet C
Transfusion; 2013 Jun; 53(6):1187-200. PubMed ID: 23067365
[TBL] [Abstract][Full Text] [Related]
16. Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus.
Prudent M; D'Alessandro A; Cazenave JP; Devine DV; Gachet C; Greinacher A; Lion N; Schubert P; Steil L; Thiele T; Tissot JD; Völker U; Zolla L
Transfus Med Rev; 2014 Apr; 28(2):72-83. PubMed ID: 24685438
[TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction.
Kerkhoffs JL; van Putten WL; Novotny VM; Te Boekhorst PA; Schipperus MR; Zwaginga JJ; van Pampus LC; de Greef GE; Luten M; Huijgens PC; Brand A; van Rhenen DJ;
Br J Haematol; 2010 Jul; 150(2):209-17. PubMed ID: 20507310
[TBL] [Abstract][Full Text] [Related]
18. Platelet Pathogen Reduction Technologies Alter the MicroRNA Profile of Platelet-Derived Microparticles.
Diallo I; Benmoussa A; Laugier J; Osman A; Hitzler WE; Provost P
Front Cardiovasc Med; 2020; 7():31. PubMed ID: 32266291
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes.
Osman A; Fälker K
Platelets; 2011; 22(6):433-41. PubMed ID: 21438667
[TBL] [Abstract][Full Text] [Related]
20. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system.
Johnson L; Loh YS; Kwok M; Marks DC
Transfus Med; 2013 Apr; 23(2):121-9. PubMed ID: 23480103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
